157 related articles for article (PubMed ID: 32659223)
1. Multi-serum glycobiomarkers improves the diagnosis and prognostic prediction of cholangiocarcinoma.
Silsirivanit A; Matsuda A; Kuno A; Tsuruno C; Uenoyama Y; Seubwai W; Angata K; Teeravirote K; Wongkham C; Araki N; Takahama Y; Wongkham S; Narimatsu H
Clin Chim Acta; 2020 Nov; 510():142-149. PubMed ID: 32659223
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the diagnostic value of Wisteria floribunda agglutinin-sialylated mucin1 and the prognostic role of mucin1 in human cholangiocarcinoma.
Tang Z; Yang Y; Wang X; Meng W; Li X
BMJ Open; 2019 Jan; 9(1):e021693. PubMed ID: 30700476
[TBL] [Abstract][Full Text] [Related]
3. Serum α2,6-sialylated glycoform of serotransferrin as a glycobiomarker for diagnosis and prediction of clinical severity in cholangiocarcinoma.
Kimawaha P; Thanan R; Jusakul A; Jamnongkan W; Silsirivanit A; Sa-Ngaimwibool P; Titapun A; Khuntikeo N; Sithithaworn P; Worasith C; Janthamala S; Lebrilla CB; Techasen A
Clin Chim Acta; 2022 Nov; 536():142-154. PubMed ID: 36174722
[TBL] [Abstract][Full Text] [Related]
4. CA-S27: a novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma.
Silsirivanit A; Araki N; Wongkham C; Vaeteewoottacharn K; Pairojkul C; Kuwahara K; Narimatsu Y; Sawaki H; Narimatsu H; Okada S; Sakaguchi N; Wongkham S
Cancer Sci; 2013 Oct; 104(10):1278-84. PubMed ID: 23809433
[TBL] [Abstract][Full Text] [Related]
5. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
6. A Novel Serum Glycobiomarker for Diagnosis and Prognosis of Cholangiocarcinoma Detected by
Teeravirote K; Luang S; Waraasawapati S; Boonsiri P; Wongkham C; Wongkham S; Silsirivanit A
Molecules; 2021 May; 26(9):. PubMed ID: 34066878
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of GalNAcylated glycans in cholangiocarcinoma: Values for diagnosis and prognosis.
Saentaweesuk W; Silsirivanit A; Vaeteewoottacharn K; Sawanyawisuth K; Pairojkul C; Cha'on U; Indramanee S; Pinlaor S; Boonmars T; Araki N; Wongkham C
Clin Chim Acta; 2018 Feb; 477():66-71. PubMed ID: 29217428
[TBL] [Abstract][Full Text] [Related]
8. Proteomics analysis and evaluation of biomarkers for detection of cholangiocarcinoma.
Sriwanitchrak P; Viyanant V; Chaijaroenkul W; Srivatanakul P; Gram HR; Eursiddhichai V; Na-Bangchang K
Asian Pac J Cancer Prev; 2011; 12(6):1503-10. PubMed ID: 22126489
[TBL] [Abstract][Full Text] [Related]
9. State of serum markers for detection of cholangiocarcinoma.
Wongkham S; Silsirivanit A
Asian Pac J Cancer Prev; 2012; 13 Suppl():17-27. PubMed ID: 23480761
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma.
Luang S; Teeravirote K; Saentaweesuk W; Ma-In P; Silsirivanit A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33207685
[No Abstract] [Full Text] [Related]
11. Improve discrimination power of serum markers for diagnosis of cholangiocarcinoma using data mining-based approach.
Pattanapairoj S; Silsirivanit A; Muisuk K; Seubwai W; Cha'on U; Vaeteewoottacharn K; Sawanyawisuth K; Chetchotsak D; Wongkham S
Clin Biochem; 2015 Jul; 48(10-11):668-73. PubMed ID: 25863112
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
[TBL] [Abstract][Full Text] [Related]
13. Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
Matsuda A; Kuno A; Matsuzaki H; Kawamoto T; Shikanai T; Nakanuma Y; Yamamoto M; Ohkohchi N; Ikehara Y; Shoda J; Hirabayashi J; Narimatsu H
J Proteomics; 2013 Jun; 85():1-11. PubMed ID: 23612463
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Liang B; Zhong L; He Q; Wang S; Pan Z; Wang T; Zhao Y
Med Sci Monit; 2015 Nov; 21():3555-63. PubMed ID: 26576628
[TBL] [Abstract][Full Text] [Related]
15. Peptidase inhibitor 15 as a novel blood diagnostic marker for cholangiocarcinoma.
Jiang Y; Zheng X; Jiao D; Chen P; Xu Y; Wei H; Qian Y
EBioMedicine; 2019 Feb; 40():422-431. PubMed ID: 30638862
[TBL] [Abstract][Full Text] [Related]
16. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
Ishii Y; Sasaki T; Serikawa M; Kobayashi K; Kamigaki M; Minami T; Okazaki A; Yukutake M; Ishigaki T; Kosaka K; Mouri T; Yoshimi S; Chayama K
Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
[TBL] [Abstract][Full Text] [Related]
17. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
Front Public Health; 2022; 10():835914. PubMed ID: 35991009
[TBL] [Abstract][Full Text] [Related]
18. FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Wannhoff A; Hov JR; Folseraas T; Rupp C; Friedrich K; Anmarkrud JA; Weiss KH; Sauer P; Schirmacher P; Boberg KM; Stremmel W; Karlsen TH; Gotthardt DN
J Hepatol; 2013 Dec; 59(6):1278-84. PubMed ID: 23958938
[TBL] [Abstract][Full Text] [Related]
19. Serum markers of intrahepatic cholangiocarcinoma.
Malaguarnera G; Paladina I; Giordano M; Malaguarnera M; Bertino G; Berretta M
Dis Markers; 2013; 34(4):219-28. PubMed ID: 23396291
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA-21 as a prognostic, biological marker in cholangiocarcinoma.
Liu CH; Huang Q; Jin ZY; Xie F; Zhu CL; Liu Z; Wang C
J Cancer Res Ther; 2018 Jan; 14(1):220-225. PubMed ID: 29516989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]